Incidental detection of malignancy during preprocedural workup for transcatheter aortic valve implantation: A longitudinal cohort study

Caglayan Demirel; Daijiro Tomii; Dik Heg; Taishi Okuno; Fabian Wieser; Thomas M Suter; Christoph Gräni; Stephan Windecker; Thomas Pilgrim

doi:10.1016/j.ahj.2023.03.011

Incidental detection of malignancy during preprocedural workup for transcatheter aortic valve implantation: A longitudinal cohort study

Am Heart J. 2023 Jul:261:51-54. doi: 10.1016/j.ahj.2023.03.011. Epub 2023 Apr 1.

Authors

Caglayan Demirel¹, Daijiro Tomii¹, Dik Heg², Taishi Okuno¹, Fabian Wieser¹, Thomas M Suter¹, Christoph Gräni¹, Stephan Windecker¹, Thomas Pilgrim³

Affiliations

¹ Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
² CTU Bern, University of Bern, Bern, Switzerland.
³ Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland. Electronic address: thomas.pilgrim@insel.ch.

PMID: 37011854
DOI: 10.1016/j.ahj.2023.03.011

Abstract

The aim of this retrospective analysis was to investigate the prevalence and prognostic importance of incidental malignancy detected during pre-TAVI computed tomography. Among 579 patients, CT-work-up for TAVI exposed previously undetected malignancy in 4.5% of patients. TAVI patients with a new malignancy had a 2.9-fold increased risk of death at 1 year, and a 16 month shorter mean survival time compared to patients with no malignancy.

Publication types

Letter

MeSH terms

Aortic Valve Stenosis* / surgery
Cohort Studies
Humans
Longitudinal Studies
Neoplasms*
Retrospective Studies
Transcatheter Aortic Valve Replacement* / adverse effects